Gradual improvement of liver function after administration of ursodeoxycholic acid in an infant with a novel ABCB11 gene mutation with phenotypic continuum between BRIC2 and PFIC2

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 11, 2007, Pages 942-946

  Takahashi, Atsushi ^a,c   Hasegawa, Makoto ^b   Sumazaki, Ryo ^b   Suzuki, Makoto ^a   Toki, Fumiaki ^a   Suehiro, Taketoshi ^a   Onigata, Kazumichi ^a   Tomomasa, Takeshi ^a   Suzuki, Tomoko ^a   Matsui, Akira ^b   Morikawa, Akihiro ^b   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Department of General Surgical Science ^*  (Japan)

Author keywords

ABCB11; Benign recurrent intrahepatic cholestasis; Bile salt export pump; Progressive familial intrahepatic cholestasis; Ursodeoxycholic acid

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER B11; BILE ACID; FAMILIAL INTRAHEPATIC CHOLESTASIS 1 PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GROWTH HORMONE; PROTEIN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; VITAMIN K GROUP;

ARTICLE; BILE ACID BLOOD LEVEL; BYLER DISEASE; CASE REPORT; CATCH UP GROWTH; DISEASE SEVERITY; DRUG EFFECT; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENETIC ANALYSIS; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HETEROZYGOSITY; HORMONAL THERAPY; HOSPITAL ADMISSION; HUMAN; INTESTINAL BLEEDING; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER TRANSPLANTATION; LUNG HEMORRHAGE; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 2; PRURITUS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; TREATMENT OUTCOME;

ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS, INTRAHEPATIC; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; GROWTH HORMONE; HUMANS; INFANT; LIVER; MALE; MUTATION, MISSENSE; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; URSODEOXYCHOLIC ACID; VITAMIN K;

EID: 37349126955     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282ef4795     Document Type: Article

References (14)

1. Jacquemin E. Cholestatic liver disease: progressive familial intrahepatic cholestasis. J Gastroenterol Hepatol 1999; 14:594-599.
2. Jacquemin E, Hadchouel M. Genetic basis of progressive familial intrahepatic cholestasis. J Hepatol 1999; 31:377-381.
3. Bull LN, Carlton VEH, Stricker NL, Baharloo S, DeYoung JA, Freimer NB, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997; 26:155-164.
4. Jansen PLM, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooivelt GJEJ, et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999; 117:1370-1379.
5. Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Sharp HL. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994; 18:134-141.
6. Alonso EM, Snover DC, Montag A, Freese DK, Whitington PF. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994; 18:128-133.
7. Van Mil SWC, Van der Woerd WL, Van der Brugge G, Sturm E, Jansen PLM, Bull LN, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004; 127:379-384.
8. Kubitz R, Keitel V, Scheuring S, Kohrer KA, Haussinger D. Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump. J Clin Gastroenterol 2006; 40:81-85.
9. Summerskill WH, Walshe LM. Benign recurrent intrahepatic 'obstructive' jaundice. Lancet 1959; 2:686-690.
10. Lam CW, Cheung KM, Tsui MS, Yan MSC, Lee CY, Tong SF. A patient with novel ABCB11 gene mutations with phenotypic transition between BRIC2 and PFIC2. J Hepatol 2006; 44:240-242.
11. Van Ooteghem NAM, Klomp LWJ, Van Berge-Henegouwen GP, Houwen RHJ. Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum. J Hepatol 2002; 36:439-443.
12. Jacquemin E, Hermans D, Myara A, Habes D, Debray D, Hadchouel M, et al. Ursodeoxycholic therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997; 25:519-523.
13. Keitel V, Burdelski M, Warskulat U, Kuhlkamp T, Keppler D, Haussinger D, et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 2005; 41:1160-1172.
14. Plass JRM, Mol O, Heegsma J, Geuken M, de Bruin J, Elling G, et al. A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump. J Hepatol 2004; 40:24-30.